1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics, August 2019

Pharmaceutical Analysis & Statistics, August 2019

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

1-30 of about 32000 reports

World Immunodiagnostic Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in Americas, EMEA, APAC--A 75-Country Survey--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

World Immunodiagnostic Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in Americas, EMEA, APAC--A 75-Country Survey--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 37500
  • Industry report
  • May 2019

World Immunodiagnostic Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in Americas, EMEA, APAC--A 75-Country Survey--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, ...

  • Industries : Therapy
  • Countries : Australasia, North America, APAC, Latin America, World, Australia, Middle East
World Clinical Chemistry Analyzers and Reagents Market in the Americas, EMEA, APAC: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 100 Tests, Technology and Instrumentation Review

World Clinical Chemistry Analyzers and Reagents Market in the Americas, EMEA, APAC: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 100 Tests, Technology and Instrumentation Review

  • $ 35000
  • Industry report
  • August 2019

World Clinical Chemistry Analyzers and Reagents Market in the Americas, EMEA, APAC: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 100 Tests, Technology and Instrumentation ...

  • Industries : Therapy
  • Countries : Australasia, North America, APAC, Latin America, World, Australia
Europe Immunodiagnostic Analyzers and Reagents Market, 2019-2023: A 31-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Europe Immunodiagnostic Analyzers and Reagents Market, 2019-2023: A 31-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 27500
  • Industry report
  • May 2019

Europe Immunodiagnostic Analyzers and Reagents Market, 2019-2023: A 31-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewThis new ...

  • Industries : Therapy
  • Countries : Northern Europe, Scandinavia, Baltics
Competing in the Global Hematology and Flow Cytometry Market, 2019-2023

Competing in the Global Hematology and Flow Cytometry Market, 2019-2023

  • $ 21100
  • Industry report
  • July 2019

Competing in the Global Hematology and Flow Cytometry Market, 2019-2023This new report contains 700 pages, 250 tables, and provides information not available from any other published source, including: ...

  • Industries : Biopharmaceutical, Biopharmaceutical
  • Countries : World
Succeeding in the Global Clinical Chemistry and Immunodiagnostics Market, 2019-2023

Succeeding in the Global Clinical Chemistry and Immunodiagnostics Market, 2019-2023

  • $ 19500
  • Industry report
  • June 2019

Succeeding in the Global Clinical Chemistry and Immunodiagnostics Market, 2019-2023: US, Europe, Japan--Analyzers and Reagents-- Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive ...

  • Industries : Therapy
  • Countries : World, Japan, United States, Europe, France, Germany, Italy, Spain, United Kingdom
Europe Clinical Chemistry Analyzers and Reagents Market in 31 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 100 Tests, Technology and Instrumentation Review

Europe Clinical Chemistry Analyzers and Reagents Market in 31 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 100 Tests, Technology and Instrumentation Review

  • $ 18500
  • Industry report
  • August 2019

Europe Clinical Chemistry Analyzers and Reagents Market in 31 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 100 Tests, Technology and Instrumentation ReviewThis ...

  • Industries : Therapy
  • Countries : Northern Europe, Scandinavia, Baltics
Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, 2019-2023

Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, 2019-2023

  • $ 18500
  • Industry report
  • July 2019

Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, 2019-2023This new report is a seven-country ...

  • Industries : Therapy
  • Countries : United States, Japan, Europe
Global Immunodiagnostics Market, 2019-2023

Global Immunodiagnostics Market, 2019-2023

  • $ 18500
  • Industry report
  • July 2019

Global Immunodiagnostics Market, 2019-2023: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 100 Tests--Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, ...

  • Industries : Therapy
Global Clinical Chemistry and Immunodiagnostics Market in the US, Europe, Japan: Supplier Shares and Sales Segment Forecasts for over 100 Test, Competitive Landscape, Emerging Technologies, Instrumentation Review

Global Clinical Chemistry and Immunodiagnostics Market in the US, Europe, Japan: Supplier Shares and Sales Segment Forecasts for over 100 Test, Competitive Landscape, Emerging Technologies, Instrumentation Review

  • $ 17500
  • Industry report
  • August 2019

Global Clinical Chemistry and Immunodiagnostics Market in the US, Europe, Japan: Supplier Shares and Sales Segment Forecasts for over 100 Test, Competitive Landscape, Emerging Technologies, Instrumentation ...

  • Industries : Therapy
  • Countries : Japan, World, United States, Europe, France, Germany, Italy, Spain, United Kingdom
Global Immunodiagnostic Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Landscape, Emerging Technologies, Instrumentation Review

Global Immunodiagnostic Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Landscape, Emerging Technologies, Instrumentation Review

  • $ 17500
  • Industry report
  • May 2019

Global Immunodiagnostic Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Landscape, Emerging ...

  • Industries : Therapy
  • Countries : Japan, World, United States, Europe, France, Germany, Italy, Spain, United Kingdom
Asia-Pacific Immunodiagnostic Analyzers and Reagents Market, 2019-2023: A 17-Country Analysis--Supplier Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review

Asia-Pacific Immunodiagnostic Analyzers and Reagents Market, 2019-2023: A 17-Country Analysis--Supplier Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review

  • $ 16500
  • Industry report
  • May 2019

Asia-Pacific Immunodiagnostic Analyzers and Reagents Market, 2019-2023: A 17-Country Analysis--Supplier Strategies, Volume and Sales Forecasts, Technology and Instrumentation ReviewThis new 17-country ...

  • Industries : Therapy
  • Countries : Australasia, APAC, Australia
Global Clinical Chemistry and Immunodiagnostic Analyzers and Reagents--Market Shares, Segmentation Forecasts for 100 Tests, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

Global Clinical Chemistry and Immunodiagnostic Analyzers and Reagents--Market Shares, Segmentation Forecasts for 100 Tests, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

  • $ 14500
  • Industry report
  • July 2019

Global Clinical Chemistry and Immunodiagnostic Analyzers and Reagents--Market Shares, Segmentation Forecasts for 100 Tests, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities ...

  • Industries : Therapy
  • Countries : World, France, Germany, Italy, Spain, United Kingdom, Japan
Europe Clinical Chemistry and Immunodiagnostics Market in France, Germany, Italy, Spain, UK: Supplier Shares and Sales Segment Forecasts for Over 100 Tests, Competitive Landscape, Emerging Technologies, Instrumentation Review

Europe Clinical Chemistry and Immunodiagnostics Market in France, Germany, Italy, Spain, UK: Supplier Shares and Sales Segment Forecasts for Over 100 Tests, Competitive Landscape, Emerging Technologies, Instrumentation Review

  • $ 12800
  • Industry report
  • August 2019

Europe Clinical Chemistry and Immunodiagnostics Market in France, Germany, Italy, Spain, UK: Supplier Shares and Sales Segment Forecasts for Over 100 Tests, Competitive Landscape, Emerging Technologies, ...

  • Industries : Therapy
  • Countries : Europe, France, Germany, Italy, Spain, United Kingdom
Europe Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--France, Germany, Italy, Spain, UK--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

Europe Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--France, Germany, Italy, Spain, UK--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 12800
  • Industry report
  • July 2019

Europe Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--France, Germany, Italy, Spain, UK--Competitive Intelligence, Technology and ...

  • Industries : Therapy
  • Countries : Europe, France, Germany, Italy, Spain, United Kingdom
Succeeding in the Europe Cancer Diagnostics Market, 2019-2023: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

Succeeding in the Europe Cancer Diagnostics Market, 2019-2023: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 12800
  • Industry report
  • June 2019

Succeeding in the Europe Cancer Diagnostics Market, 2019-2023: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, ...

  • Industries : Medical Biotechnology, Diagnostics, Biopharmaceutical, Biopharmaceutical, Diagnostic Imaging
  • Countries : Europe, France, Germany, Italy, Spain, United Kingdom
Succeeding in the Europe Clinical Chemistry and Immunodiagnostics Market, 2019-2023: France, Germany, Italy, Spain, UK--Analyzers and Reagents

Succeeding in the Europe Clinical Chemistry and Immunodiagnostics Market, 2019-2023: France, Germany, Italy, Spain, UK--Analyzers and Reagents

  • $ 12800
  • Industry report
  • June 2019

Succeeding in the Europe Clinical Chemistry and Immunodiagnostics Market, 2019-2023: France, Germany, Italy, Spain, UK--Analyzers and ReagentsThis new report is a five-country strategic analysis of majo ...

  • Industries : Therapy
  • Countries : France, Germany, Italy, Spain, Europe, United Kingdom
Europe Immunodiagnostic Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in France, Germany, Italy, Spain, UK

Europe Immunodiagnostic Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • May 2019

Europe Immunodiagnostic Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in France, Germany, Italy, Spain, UKThis new report is a five-country strategic analysis of major business opportunities ...

  • Industries : Therapy
  • Countries : Europe, France, Germany, Italy, Spain, United Kingdom
Succeeding in the Global Flow Cytometry Market, 2019-2023: US, Europe, Japan--Analyzer and Reagents--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

Succeeding in the Global Flow Cytometry Market, 2019-2023: US, Europe, Japan--Analyzer and Reagents--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 12000
  • Industry report
  • June 2019

Succeeding in the Global Flow Cytometry Market, 2019-2023: US, Europe, Japan--Analyzer and Reagents--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging ...

  • Industries : Biopharmaceutical, Biopharmaceutical
  • Countries : World, United States, Europe, Japan
Trogarzo

Trogarzo

  • $ 10000
  • Industry report
  • July 2019

Trogarzo (ibalizumab; Theratechnologies/TaiMed Biologics) is a recombinant humanized monoclonal antibody approved for the treatment of HIV-1 infection. It targets the HIV-1 post-attachment process by binding ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Therapy
  • Countries : United States
Delstrigo

Delstrigo

  • $ 10000
  • Industry report
  • July 2019

Delstrigo ([doravirine + lamivudine + tenofovir disoproxil fumarate (TDF)]; Merck and Co) is a single-tablet regimen being developed for the treatment of HIV-1 infection. The drug is a co-formulation of ...

  • Industries : Therapy
  • Countries : United States, European Union
Descovy

Descovy

  • $ 10000
  • Industry report
  • July 2019

Descovy ([emtricitabine + tenofovir alafenamide (TAF)]; Gilead/Japan Tobacco) is a fixed-dose combination of two of Gilead’s nucleos(t)ide reverse transcriptase inhibitors, Emtriva (emtricitabine) and ...

  • Industries : Therapy
  • Countries : United States, European Union, Japan
VK2809

VK2809

  • $ 10000
  • Industry report
  • July 2019

VK2809 (Viking Therapeutics) is a thyroid hormone receptor (THR) ?-selective agonist which is selective to liver tissue. It is delivered as a prodrug. VK2809 selectively activates the cytochrome P450 isozyme ...

  • Industries : Therapy
Ocaliva

Ocaliva

  • $ 10000
  • Industry report
  • July 2019

Ocaliva (obeticholic acid; Intercept Pharmaceuticals) is a selective farnesoid X receptor (FXR) agonist. FXR is a nuclear bile acid receptor involved in the regulation of bile acids, lipids, and possibly ...

  • Industries : Therapy
  • Countries : United States, European Union
Juluca

Juluca

  • $ 10000
  • Industry report
  • June 2019

Juluca ([dolutegravir + rilpivirine]; ViiV Healthcare/Johnson and Johnson) is a single-tablet regimen approved in the US for the treatment of patients infected with HIV-1 who have achieved viral supp ...

  • Industries : Therapy
  • Countries : United States, European Union
Prezista franchise

Prezista franchise

  • $ 10000
  • Industry report
  • June 2019

The Prezista franchise comprises the standalone protease inhibitor (PI) Prezista (darunavir; Johnson and Johnson) and the fixed-dose combination of Prezista and Tybost (cobicistat; Gilead), which is branded ...

  • Industries : Therapy
  • Countries : United States, European Union
cabotegravir/rilpivirine

cabotegravir/rilpivirine

  • $ 10000
  • Industry report
  • June 2019

Cabotegravir is an integrase strand transfer inhibitor analog of Tivicay (dolutegravir; ViiV Healthcare), and rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI), branded as Edurant ...

  • Industries : Therapy
  • Countries : United States, European Union
Biktarvy

Biktarvy

  • $ 10000
  • Industry report
  • June 2019

Biktarvy ([bictegravir + emtricitabine + tenofovir alafenamide (TAF)]; Gilead) is an single-tablet regimen (STR) approved for the treatment of HIV-1 infection. It is a co-formulation of Gilead’s novel ...

  • Industries : Therapy
  • Countries : United States, Japan, European Union
Complera

Complera

  • $ 10000
  • Industry report
  • June 2019

Complera (rilpivirine/emtricitabine/tenofovir disoproxil fumarate [TDF]; Gilead/Johnson and Johnson) is a single-tablet regimen for the treatment of HIV-1 infection.

  • Industries : Therapy
  • Countries : United States, European Union
Symtuza

Symtuza

  • $ 10000
  • Industry report
  • June 2019

Symtuza ([darunavir + cobicistat + emtricitabine + tenofovir alafenamide (TAF)]; Johnson and Johnson) is a once-daily single-tablet regimen (STR) combination of the protease inhibitor (PI) Prezista, the ...

  • Industries : Therapy
  • Countries : United States, European Union
Atripla

Atripla

  • $ 10000
  • Industry report
  • June 2019

Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate [TDF]; Gilead/Bristol-Myers Squibb) is a single-tablet regimen approved for the treatment of HIV-1 infection.

  • Industries : Therapy
  • Countries : United States, European Union

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on